SAN

76.26

-1.73%↓

UCB

250.1

-3.1%↓

SHL.DE

40.38

-0.02%↓

ARGX

620.4

-1.02%↓

PHIA

24.97

-2.19%↓

SAN

76.26

-1.73%↓

UCB

250.1

-3.1%↓

SHL.DE

40.38

-0.02%↓

ARGX

620.4

-1.02%↓

PHIA

24.97

-2.19%↓

SAN

76.26

-1.73%↓

UCB

250.1

-3.1%↓

SHL.DE

40.38

-0.02%↓

ARGX

620.4

-1.02%↓

PHIA

24.97

-2.19%↓

SAN

76.26

-1.73%↓

UCB

250.1

-3.1%↓

SHL.DE

40.38

-0.02%↓

ARGX

620.4

-1.02%↓

PHIA

24.97

-2.19%↓

SAN

76.26

-1.73%↓

UCB

250.1

-3.1%↓

SHL.DE

40.38

-0.02%↓

ARGX

620.4

-1.02%↓

PHIA

24.97

-2.19%↓

Search

Merck KGaA

Closed

SectorHealthcare

110.05 -3.72

Overview

Share price change

24h

Current

Min

109.55

Max

114.3

Key metrics

By Trading Economics

Income

250M

902M

Sales

63M

5.3B

Dividend yield

1.34

Profit margin

16.961

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+31.63% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

1.34%

2.25%

Next Earnings

13 May 2026

Market Stats

By TradingEconomics

Market Cap

98B

Previous open

113.77

Previous close

110.05

News Sentiment

By Acuity

29%

71%

72 / 351 Healthcare

Technical Score

By Trading Central

Confidence

Strong Bearish Evidence

Merck KGaA Chart

Past performance is not a reliable indicator of future results.

Related News

5 Mar 2026, 06:28 UTC

Earnings

Germany's Merck KGaA Expects Currency Headwinds to Weigh on Earnings

13 Nov 2025, 13:40 UTC

Earnings

Germany's Merck KGaA Shares Rise After Semiconductor, Pharma Demand Boost Results -- Update

13 Nov 2025, 06:24 UTC

Earnings

Germany's Merck KGaA Posts Higher Earnings on Organic Growth Across Units

5 Mar 2026, 08:40 UTC

Market Talk

Germany's Merck KGaA Issues Weaker-Than-Expected Guidance -- Market Talk

5 Mar 2026, 06:00 UTC

Earnings

Merck KGaA Sees 2026 Ebitda Before Special Items at EUR5.5B-EUR6B

5 Mar 2026, 06:00 UTC

Earnings

Merck KGaA Sees 2026 Adj EPS EUR7.10-Adj EPS EUR8

5 Mar 2026, 06:00 UTC

Earnings

Analysts Saw Merck KGaA 2025 Ebitda Before Special Items EUR6.1B

5 Mar 2026, 06:00 UTC

Earnings

Merck KGaA Sees 2026 Sales EUR20B-EUR21B

5 Mar 2026, 06:00 UTC

Earnings

Merck KGaA Sees 2026 Organic Net Sales Ranging From 1% Fall to 2% Rise

5 Mar 2026, 06:00 UTC

Earnings

Merck KGaA 2025 Adj EPS EUR8.34

5 Mar 2026, 06:00 UTC

Earnings

Analysts Saw Merck KGaA 2025 Net Sales at EUR21.14B

5 Mar 2026, 06:00 UTC

Earnings

Merck KGaA Expects Considerable Foreign-Exchange Headwinds in 2026

5 Mar 2026, 06:00 UTC

Earnings

Merck KGaA Keeps Dividend at EUR2.20 a Share

5 Mar 2026, 06:00 UTC

Earnings

Merck KGaA 2025 After-Tax Profit EUR2.615B

5 Mar 2026, 06:00 UTC

Earnings

Germany's Merck KGaA Says Organic Net Sales Grew 3.1% in 2025

5 Mar 2026, 06:00 UTC

Earnings

Merck KGaA 2025 Sales EUR21.1B

5 Mar 2026, 06:00 UTC

Earnings

Merck KGaA 2025 Ebitda Before Special Items EUR6.11B

12 Feb 2026, 15:20 UTC

Earnings

Sanofi Shares Fall After CEO Change -- Update

20 Jan 2026, 09:54 UTC

Market Talk
Acquisitions, Mergers, Takeovers

DAVOS: Merck KGaA Not in a Hurry for M&A, CEO Says -- Market Talk

13 Nov 2025, 07:57 UTC

Market Talk
Earnings

Germany's Merck KGaA Beats Expectations With Strong Results -- Market Talk

13 Nov 2025, 06:00 UTC

Earnings

Merck KGaA Sees 2025 Ebitda Before Exceptional Items at EUR6B-EUR6.2B

13 Nov 2025, 06:00 UTC

Earnings

Merck KGaA Narrows 2025 View To Sales EUR20.8B-EUR21.4B

13 Nov 2025, 06:00 UTC

Earnings

Merck KGaA Sees 2025 Organic Ebitda Before Exceptional Items Growth of 5%-7%

13 Nov 2025, 06:00 UTC

Earnings

Merck KGaA Had Guided for 2025 Organic Sales Growth of 2% to 5%

13 Nov 2025, 06:00 UTC

Earnings

Merck KGaA Says Guidance Midpoint Remains Unchanged

13 Nov 2025, 06:00 UTC

Earnings

Merck KGaA Had Guided for 2025 Organic Ebitda Before Exceptional Items Growth of 4%-8%

13 Nov 2025, 06:00 UTC

Earnings

Merck KGaA Sees 2025 Organic Sales Growth of Around 3%

13 Nov 2025, 06:00 UTC

Earnings

Merck KGaA 3Q After-Tax Profit EUR898M

13 Nov 2025, 06:00 UTC

Earnings

Merck KGaA: 3Q Net Sales Rose 5.2% Organically With Solid Growth Across Sectors

13 Nov 2025, 06:00 UTC

Earnings

Merck KGaA Narrows 2025 View

Peer Comparison

Price change

Merck KGaA Forecast

Price Target

By TipRanks

31.63% upside

12 Months Forecast

Average 149 EUR  31.63%

High 182 EUR

Low 130 EUR

Based on 7 Wall Street analysts offering 12 month price targets forMerck KGaA - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

7 ratings

5

Buy

2

Hold

0

Sell

Technical Score

By Trading Central

121.15 / 123.55Support & Resistance

Short Term

Strong Bearish Evidence

Intermediate Term

Neutral Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

72 / 351 Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Merck KGaA

There is no Profile data available for MRK.BE.
help-icon Live chat